PTJ
STOK icon

Paul Tudor Jones’s Stoke Therapeutics STOK Stock Holding History

Paul Tudor Jones’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,309
Closed -$613K – 4242
2025
Q4 		$613K Buy
+19,309
New +$580K ﹤0.01% 2595
2025
Q1 		– Sell
-18,258
Closed -$201K – 3651
2024
Q4 		$201K Buy
+18,258
New +$224K ﹤0.01% 2845
2024
Q3 		– Sell
-18,402
Closed -$249K – 3094
2024
Q2 		$249K Sell
18,402
-14,924
-45% -$202K ﹤0.01% 2082
2024
Q1 		$450K Buy
+33,326
New +$202K ﹤0.01% 1689
2023
Q4 		– Sell
-18,252
Closed -$71.9K – 2877
2023
Q3 		$71.9K Hold
18,252
– – ﹤0.01% 2167
2023
Q2 		$194K Buy
18,252
+53
+0.3% +$564 ﹤0.01% 2236
2023
Q1 		$152K Sell
18,199
-114
-0.6% -$1.03K ﹤0.01% 2215
2022
Q4 		$169K Hold
18,313
– – ﹤0.01% 2162
2022
Q3 		$235K Buy
18,313
+1,889
+12% +$30.1K 0.01% 1961
2022
Q2 		$217K Sell
16,424
-1,095
-6% -$16.6K 0.01% 1770
2022
Q1 		$369K Sell
17,519
-1,958
-10% -$39.2K 0.01% 1447
2021
Q4 		$467K Buy
+19,477
New +$465K 0.01% 1528
2019
Q3 		– Sell
-7,500
Closed -$219K – 1323
2019
Q2 		$219K Buy
+7,500
New +$201K 0.01% 944

Other funds holding STOK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Paul Tudor Jones's STOK Position: Q1 2026 in Review

Paul Tudor Jones sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 19,309 shares — an estimated $613K sold.

Paul Tudor Jones first reported a position in STOK in Q2 2019 and held it in 13 quarters. The position peaked at $613K in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Paul Tudor Jones reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 19,309 Stoke Therapeutics shares in Q1 2026, an estimated $613K.
  • Paul Tudor Jones first reported a position in Stoke Therapeutics in Q2 2019 and held it in 13 quarters.
  • Paul Tudor Jones's Stoke Therapeutics position peaked at $613K in Q4 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.